Chronic inflammation is known to play a key role in severe dry eye disease (DED), contributing to a self-perpetuating cycle of ocular surface damage. Inflammatory mediators and proteases released are key drivers of clinical signs and symptoms1,2.
Create a free Member account at NZ Optics to read this article and more.
US neuro-optometrist Dr Bryce Appelbaum's brain-based vision training model improved UK GP Dr Rangan Chatterjee's una
An optometrist recounts her experience on an Eyes4Everest outreach trip to Nepal's Annapurna region, providing eyecare at high-altitude
Veteran Auckland optometrist Trevor Skinner retires after nearly 50 years, known for his patient-first approach, empathy, and passion for optometry, having
Artificial intelligence (AI) use in eyecare is moving fast, but are regulation, ethics and real-world integration keeping pace? As clinicians and regulators grapple with how to harness its potential without compromising patient safety or equity, Drew Jones examines where AI use in eyecare stands and
February is my favourite time of the year. Not only is there beautiful summer weather and warm seawater, but this is the time when the Australian and New Zealand Glaucoma Society (ANZGS) Congress takes place! This year’s meeting was in Sydney CBD’s Masonic Centre. It’s a fabulous venue with beautifu
As cutting-edge ZEISS diagnostic technology becomes increasingly prevalent in the ophthalmic industry, it has elevated patient care within a busy Auckland optometry practice. Frith Jenkins from Howick